Tunib 50mg Capsule is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Tivozanib, a potent tyrosine kinase inhibitor. Tivozanib works by blocking the activity of specific enzymes that are crucial for the growth and proliferation of cancer cells, particularly those involved in the formation of new blood vessels that feed tumors (angiogenesis). By inhibiting these pathways, Tunib helps to slow down or stop the progression of cancer.
Tunib 50mg Capsule is primarily indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) after two or more prior systemic therapies. It is important to note that this medication should only be used under the guidance of a qualified healthcare professional.
The typical dosage and administration of Tunib 50mg Capsule will be determined by your doctor based on your individual condition and response to treatment. It is usually taken orally. Common side effects may include fatigue, diarrhea, hypertension, decreased appetite, nausea, stomatitis, and weight loss. Serious side effects can occur, and it is crucial to report any unusual symptoms to your doctor immediately.
Store Tunib 50mg Capsules at room temperature, away from moisture and direct light. Keep out of reach of children.
